Physician profile
Jason Kim
NPI 1790793750
$426,960.57
in general payments reported to CMS, 2019-2025
10 companies · $47K in 2025
The $47K reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,659 · 2020: $43K · 2021: $22K · 2022: $108K · 2023: $101K · 2024: $102K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $209K · Travel and Lodging: $33K · Food and Beverage: $7,215 · Education: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $208,505.55 |
| Travel and Lodging | $32,696.39 |
| Food and Beverage | $7,215.25 |
| Education | $1,051.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $329,562.27 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $95,820.26 | 2019-2022 | |
| Patterson Companies, INC. | $750.00 | 2024 | |
| Dentsply Sirona INC | $489.00 | 2024 | |
| Align Technology, INC. | $153.73 | 2020-2025 | Invisalign |
| Merz North America, INC. | $50.08 | 2025 | |
| Geistlich Pharma, North America, INC. | $45.04 | 2025 | Biomaterials |
| Orapharma, A Division of Bausch Health US, LLC | $39.12 | 2024-2025 | Arestin |
| Biohorizons Implant Systems INC. | $26.07 | 2019 | |
| Straumann USA LLC | $25.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.